Skip to main content

Incidence Rates of Soft Tissue Sarcoma Lower in Servicemen

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 9, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Dec. 9, 2024 -- The incidence rates of soft tissue sarcoma (STS) are lower among servicemen than men in the general U.S. population, according to a study published online Dec. 9 in Cancer.

Julie A. Bytnar, Dr.P.H., from the Uniformed Services University of the Health Sciences in Bethesda, Maryland, and colleagues compared the incidence of STS from 1990 to 2013 between active‐duty servicemen in the Department of Defense Automated Central Tumor Registry (ACTUR) and men in the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program, aged 18 to 59 years.

The researchers found that STS incidence rates were lower in ACTUR than SEER overall and for 18- to 39-year-old men (incidence rate ratio [IRRs], 0.86 and 0.78, respectively). Incidence rates were also lower by race (IRRs, 0.85 and 0.77 for Whites and Blacks, respectively), for sites other than skin/connective/soft tissue (IRR, 0.49), for other specified histologies and for unspecified histology (IRRs, 0.84 and 0.57, respectively). Even when stratified by race and age, rates were lower in ACTUR for regional and distant metastases (IRRs, 0.37 and 0.58, respectively). For 40- to 59-year-old men and localized tumors, rates were higher in ACTUR (IRRs, 1.25 and 1.16, respectively).

"We found lower incidence rates and earlier‐stage STS disease among active‐duty military servicemen than the general U.S. population. This may result from earlier detection and treatment, better baseline health, and access to health care," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections

WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...

AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer

TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...

AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors

TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.